Article thumbnail

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

By Farshid Dayyani, Carol J Etzel, Mei Liu, Chung-Han Ho, Scott M Lippman and Anne S Tsao
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2908081
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). Ang K: Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129. J Clin Oncol
  2. (1996). AW: A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer detection and prevention
  3. (2004). BR: The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head & neck
  4. (2008). CA: a cancer journal for clinicians
  5. (2008). Campisi G: HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol
  6. (2009). Carey T: Association of tobacco (T) use with risk of distant metastases (DM), tumor recurrence, and death in patients (pts) with HPV-positive (+) squamous cell cancer of the oropharynx (SCCOP).
  7. (2008). Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
  8. (2007). Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. International journal of cancer
  9. (2009). Controversies surrounding Human Papilloma Virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head & neck oncology
  10. (2009). Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Annals of internal medicine
  11. (2008). DA: Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients. Acta oto-laryngologica
  12. (2008). Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
  13. (1989). E: The human papilloma virus16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
  14. (2009). Effect of HPV-Associated
  15. (2008). EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
  16. (1994). Epidemiology and risk factors for head and neck cancer. Seminars in oncology
  17. (2007). et al.: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet
  18. (1998). et al.: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer research
  19. (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
  20. (2003). Fuchs PG: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. The American journal of pathology
  21. (2006). Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res
  22. (2002). H: Papillomaviruses and cancer: from basic studies to clinical application. Nature reviews
  23. (2006). High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
  24. (1990). Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53.
  25. (2006). Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. International journal of cancer
  26. (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev
  27. (2005). JP: Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Advances in oto-rhino-laryngology
  28. (2009). JS: Evaluating the impact of human papillomavirus vaccines. Vaccine
  29. (2001). KV: Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Current opinion in oncology
  30. (2007). ML: Case-control study of human papillomavirus and oropharyngeal cancer. The New England journal of medicine
  31. (2008). ML: Improved survival of patients with human papillomaviruspositive head and neck squamous cell carcinoma in a prospective clinical trial.
  32. (2006). Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
  33. (2007). O'Brien CJ: Role of human papillomavirus in the etiology of head and neck cancer. Head & neck
  34. (2008). p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Human pathology
  35. (2009). Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial.
  36. (2007). Quadrivalent vaccine against human papillomavirus to prevent highgrade cervical lesions. The New England journal of medicine
  37. (2008). Ramaekers FC, Speel EJ: Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. International journal of cancer
  38. (2005). RC: Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer
  39. (2007). Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. International journal of radiation oncology, biology, physics
  40. (2008). Rocco JW: COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer research
  41. (2009). Rocco JW: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg
  42. (2008). Sastre-Garau X: Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer letters
  43. (2009). SJ: Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ (Clinical research ed)
  44. (2006). SM: 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. British journal of cancer
  45. (2007). Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and metaanalysis. International journal of cancer
  46. (2008). TH, Turek LP: P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral oncology
  47. (2006). Thomas SJ: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol
  48. (2008). WM: Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res
  49. (1994). Xiong Y: Transcriptional repression of the Dtype cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer research